Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Oct 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022	Jun 30, 2021
Market Cap	287	225	113	35	44	113
Market Cap Growth	-65.38%	99.00%	222.74%	-20.02%	-61.24%	195.63%
Enterprise Value	98.65	1.63	106.55	-8.66	-11.74	49.94
Last Close Price	3.86	3.19	4.02	2.47	3.09	7.98
PE Ratio	-	-2.59	-2.31	-3.09	-6.18	-26.60
PS Ratio	225.15	155.05	79.00	-	-	11.27
PB Ratio	1.08	0.78	1.51	0.64	0.72	1.68
P/TBV Ratio	1.05	0.71	1.43	0.64	0.72	1.23
P/FCF Ratio	-	-3.10	-2.98	-4.40	-5.50	-35.19
P/OCF Ratio	-	-12.32	-3.07	-4.55	-5.69	-39.92
EV/Sales Ratio	79.88	1.12	74.31	-	-	4.97
EV/EBITDA Ratio	-	-0.02	-2.67	1.03	1.90	-15.15
EV/EBIT Ratio	-	-0.02	-2.60	1.00	1.83	-14.49
EV/FCF Ratio	-	-0.02	-2.81	1.08	1.47	-15.52
Debt / Equity Ratio	0.01	0.01	0.03	0	0.00	0.01
Debt / EBITDA Ratio	-0.04	-0.05	-0.06	-	-0.08	-0.23
Debt / FCF Ratio	-0.03	-0.06	-0.07	-	-0.07	-0.24
Asset Turnover	0.00	0.01	0.02	0	0	0.25
Inventory Turnover	-	-	-	0	0	6.07
Quick Ratio	14.77	12.45	0.66	16.43	25.37	36.56
Current Ratio	15.09	12.68	1.07	17.07	26.18	37.37
Return on Equity (ROE)	-26.92%	-42.82%	-57.70%	-14.21%	-9.79%	-9.26%
Return on Assets (ROA)	-26.20%	-40.33%	-49.02%	-13.50%	-9.52%	-8.71%
Return on Capital (ROIC)	-74.91%	-89.15%	-78.26%	-104.92%	-110.77%	-68.87%
Return on Capital Employed (ROCE)	-27.52%	-44.87%	-59.68%	-14.03%	-9.82%	-9.10%
Earnings Yield	-33.12%	-38.56%	-43.28%	-32.39%	-16.18%	-3.76%
FCF Yield	-40.04%	-32.25%	-33.53%	-22.73%	-18.17%	-2.84%
Buyback Yield / Dilution	-0.44%	-128.38%	-0.81%	-0.28%	-0.22%	-57.16%
Total Shareholder Return	-	-128.38%	-0.81%	-0.28%	-0.22%	-57.16%

Updated Aug 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q